Table 7.
Drugs (mg/mL) | Organisms (zone of inhibition [mm]) | ||||
---|---|---|---|---|---|
Pseudomonas aeruginosa | Klebsiella pneumoniae | Candida albicans | Escherichia coli | Staphylococcus aureus | |
PCFH | |||||
12.5 | 2.67 ± 4.6 | 2.67 ± 4.6 | 3.33 ± 5.8 | 7.67 ± 0.6 | - |
25 | 9.00 ± 0.0 | 7.00 ± 6.2 | 11.00 ± 2.0 | 9.33 ± 0.6 | - |
50 | 10.00 ± 0.0 | 11.33 ± 0.6 | 12.00 ± 2.6 | 10.67 ± 0.6 | - |
100 | 11.67 ± 1.2 | 12.67 ± 0.6 | 13.33 ± 1.5 | 12.00 ± 1.0 | - |
200 | 13.67 ± 2.1 | 13.0 ± 1.7 | 14.33 ± 2.5 | 14.33 ± 0.6 | - |
Ciprofloxacin∗ | 24.00 ± 3.0 | 24.67 ± 1.2 | 24.67 ± 1.2 | 27.33 ± 1.2 | 23.67 ± 2.5 |
Fluconazole# | - | - | 27.33 ± 3.1 | - | - |
Values are mean ± SD, n = 3, diameters of zones of inhibition after incubation of test organisms with increasing concentrations of PCFHE. PCFHE: P. clappertoniana fruit husk extract; -: no zone of inhibition or not applicable; ∗(0.01 mg/mL); #(1 mg/mL).